Linked research, clinical, and regulatory source pathways.
Company profile
About Bay Labs
Bay Labs is a health AI company operating in the cardiology and cardiovascular health sector. While the company's website is currently under construction, Bay Labs has been known in the health AI space for developing artificial intelligence solutions aimed at improving cardiovascular diagnostics and care delivery. The company appears to be in a transition phase or undergoing significant updates to its digital presence. Based on its categorization in cardiology and cardiovascular health, Bay Labs likely focuses on applying AI and machine learning technologies to cardiac imaging, diagnostics, or clinical decision support for cardiovascular conditions. Further details about the company's current operations, products, and strategic direction are not publicly available at this time.
Company description Bay Labs official website
Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Bay Labs?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cardiovascular disease
Who it serves
No customer types are currently listed.
Deployment & integration
Deployment information is currently being developed.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.Circulation research · May 13, 2022
Automated Echocardiographic Quantification of Left Ventricular Ejection Fraction Without Volume Measurements Using a Machine Learning Algorithm Mimicking a Human Expert.Circulation. Cardiovascular imaging · Sep 1, 2019
Clinical validation
Clinical-trial records
Artificial Intelligence in EchocardiographyNCT03936413 · Mentioned · WITHDRAWN
SHAPE:SeeingtheHeartwithAIPoweredEchoNCT03705650 · Mentioned · COMPLETED
Point-of-Care Echocardiography With Assistance TechnologyNCT03897140 · Mentioned · COMPLETED
Regulatory
Regulatory records
Caption GuidanceDEN190040 · De Novo · Feb 7, 2020
EchoMD Automated Ejection Fraction SoftwareK173780 · 510k · Jun 14, 2018
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Bay Labs
Recent articles published on Bay Labs's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Cardiology & Cardiovascular Health
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.